GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iXensor Co Ltd (ROCO:6734) » Definitions » Net Income From Continuing Operations

iXensor Co (ROCO:6734) Net Income From Continuing Operations : NT$-63.19 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is iXensor Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. iXensor Co's net income from continuing operations for the six months ended in Dec. 2023 was NT$-28.90 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-63.19 Mil.

iXensor Co Net Income From Continuing Operations Historical Data

The historical data trend for iXensor Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iXensor Co Net Income From Continuing Operations Chart

iXensor Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
Get a 7-Day Free Trial -104.65 -76.61 -73.08 -4.89 -63.19

iXensor Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.48 12.48 -17.37 -34.29 -28.90

iXensor Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-63.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iXensor Co (ROCO:6734) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iXensor Co Ltd (ROCO:6734) » Definitions » Net Income From Continuing Operations
Comparable Companies
ROCO:4183 ROCO:6758 ROCO:4198 ROCO:1781 ROCO:3373 ROCO:6797 ROCO:6767 ROCO:7555 ROCO:4188 ROCO:6649 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No. 9, Lane 2, Lane 35, Jihu Road, 6th Floor, Neihu District, Taipei, TWN, 11492
Website
https://www.ixensor.com
iXensor Co Ltd is a Taiwan based company involved in research and development, manufacturing and sales of medical equipment. Its PixoTest technology utilizes the lighting and image sensing module of the smartphone or mobile device to detect the color change reaction on the biochemical test strip. This enables the users to monitor their conditions of diabetes, cardiovascular diseases, women health problems, or infectious diseases.

iXensor Co (ROCO:6734) Headlines

No Headlines